person · Reporting owner
Nelli James Patrick Jr.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Health Catalyst, Inc.HCAT · Entity 1565 | President | September 01, 2022 | September 06, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Health Catalyst, Inc.
Report date September 01, 2022 · Filed September 06, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 265,025 |
Reported balance
After 2022-09-01 transaction · row 1
1 source rowRow 1 · 2022-09-01 · Tax withholding · Disposed 3,359 · Balance 265,025 F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2022 Filed Sep 6, 2022 20:10 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 3,359 | $11.61 | $38,981.20 |
DisclosureSEC source: 0001562180-22-006490 · primarydocument.xml · nonDerivative · entry 1 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,025 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 118 | $14.95 | $1,764.36 |
DisclosureSEC source: 0001562180-22-004813 · primarydocument.xml · nonDerivative · entry 2 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,384 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: Represents the weighted average sale price of the shares sold ranging from $14.91 to $15.07 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 3,241 | $14.24 | $46,142.44 |
DisclosureSEC source: 0001562180-22-004813 · primarydocument.xml · nonDerivative · entry 1 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,502 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: Represents the weighted average sale price of the shares sold ranging from $13.91 to $14.90 per share, inclusive. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 00:36 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 671 | $26.69 | $17,911.07 |
DisclosureSEC source: 0001562180-22-002345 · primarydocument.xml · nonDerivative · entry 4 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,743 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F5 · price: Represents the weighted average sale price of the shares sold ranging from $25.29 to $27.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (5). Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:36 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 8,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002345 · primarydocument.xml · nonDerivative · entry 3 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,414 F4 · shares: Represents an award of 8,385 PRSUs pursuant to the 2019 Plan. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2021, 25% of the PRSUs noted above vested on March 1, 2022 and, thereafter, the remaining 75% of the PRSUs will vest in 12 equal quarterly installments. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:36 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 3,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002345 · primarydocument.xml · nonDerivative · entry 2 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,029 F3 · shares: Represents an award of 3,164 performance-based restricted units ("PRSUs") pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2021, the PRSUs noted above vested on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:36 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 4,121 | $26.63 | $109,745.11 |
DisclosureSEC source: 0001562180-22-002345 · primarydocument.xml · nonDerivative · entry 1 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,865 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: Represents the weighted average sale price of the shares sold ranging from $26.23 to $27.44 per share, inclusive. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 02:23 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002016 · primarydocument.xml · nonDerivative · entry 1 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,986 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2022 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 23:02 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,051 | $0.00 Strike: $10.66 | $0.00 |
DisclosureSEC source: 0001562180-22-001530 · primarydocument.xml · derivative · entry 4 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,051 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 15,087 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on April 27, 2021. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 23:02 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,009 | $0.00 Strike: $10.72 | $0.00 |
DisclosureSEC source: 0001562180-22-001530 · primarydocument.xml · derivative · entry 3 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,764 Underlying: Common Stock · 2,009 shares Expires 2027-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the 12,773 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on April 26, 2021. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 23:02 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 12,051 | $10.66 | $128,463.66 |
DisclosureSEC source: 0001562180-22-001530 · primarydocument.xml · nonDerivative · entry 2 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 23:02 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 2,009 | $10.72 | $21,536.48 |
DisclosureSEC source: 0001562180-22-001530 · primarydocument.xml · nonDerivative · entry 1 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 22:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,464 | $0.00 Strike: $9.24 | $0.00 |
DisclosureSEC source: 0001562180-21-007708 · primarydocument.xml · derivative · entry 6 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,464 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 18,500 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on February 10, 2019. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 22:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,500 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001562180-21-007708 · primarydocument.xml · derivative · entry 5 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,500 shares Expires 2026-10-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 6,500 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on October 14, 2020. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 22:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,036 | $0.00 Strike: $10.66 | $0.00 |
DisclosureSEC source: 0001562180-21-007708 · primarydocument.xml · derivative · entry 4 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,051 Underlying: Common Stock · 3,036 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the 15,087 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on April 27, 2021. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 22:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 15,464 | $9.24 | $142,887.36 |
DisclosureSEC source: 0001562180-21-007708 · primarydocument.xml · nonDerivative · entry 3 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 22:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 6,500 | $10.60 | $68,900.00 |
DisclosureSEC source: 0001562180-21-007708 · primarydocument.xml · nonDerivative · entry 2 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 22:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 3,036 | $10.66 | $32,363.76 |
DisclosureSEC source: 0001562180-21-007708 · primarydocument.xml · nonDerivative · entry 1 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2021 Filed Dec 7, 2021 21:13 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 11,172 | $41.95 | $468,637.47 |
DisclosureSEC source: 0001562180-21-007527 · primarydocument.xml · nonDerivative · entry 1 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,926 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: Represents a weighted average price reported by the broker. These shares were sold as part of a block trade in multiple transactions at prices ranging from $40.33 to $42.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote with regard to the block trade. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 21:16 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,812 | $0.00 Strike: $10.72 | $0.00 |
DisclosureSEC source: 0001562180-21-005950 · primarydocument.xml · derivative · entry 6 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,047 Underlying: Common Stock · 7,812 shares Expires 2027-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the 80,977 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on October 26, 2021. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 21:16 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 18,188 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-005950 · primarydocument.xml · derivative · entry 5 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,233 Underlying: Common Stock · 18,188 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 215,741 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 21:16 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 4,627 | $54.44 | $251,908.22 |
DisclosureSEC source: 0001562180-21-005950 · primarydocument.xml · nonDerivative · entry 4 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,098 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 10, 2021 in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $55.32 to $56.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth Footnotes (2) and (3). Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 21:16 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 24,753 | $54.83 | $1,357,315.90 |
DisclosureSEC source: 0001562180-21-005950 · primarydocument.xml · nonDerivative · entry 3 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,725 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 10, 2021 in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $54.32 to $55.31, inclusive. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 21:16 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 7,812 | $10.72 | $83,744.64 |
DisclosureSEC source: 0001562180-21-005950 · primarydocument.xml · nonDerivative · entry 2 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 21:16 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 18,188 | $10.80 | $196,430.40 |
DisclosureSEC source: 0001562180-21-005950 · primarydocument.xml · nonDerivative · entry 1 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:06 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 2,870 | $54.23 | $155,646.13 |
DisclosureSEC source: 0001562180-21-005797 · primarydocument.xml · nonDerivative · entry 1 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,478 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.91 to $54.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 22:12 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 480 | $57.09 | $27,403.92 |
DisclosureSEC source: 0001562180-21-004374 · primarydocument.xml · nonDerivative · entry 2 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,348 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 10, 2021 in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $56.96 to $57.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth Footnotes (2) and (3). Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 22:12 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,950 | $56.40 | $166,383.25 |
DisclosureSEC source: 0001562180-21-004374 · primarydocument.xml · nonDerivative · entry 1 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,828 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 10, 2021 in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $55.93 to $56.89, inclusive. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 23:34 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 2,820 | $53.88 | $151,929.47 |
DisclosureSEC source: 0001562180-21-004056 · primarydocument.xml · nonDerivative · entry 1 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,778 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.66 to $54.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. Read SEC document |
| May 11, 2021 Filed May 13, 2021 22:08 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,430 | $0.00 Strike: $10.72 | $0.00 |
DisclosureSEC source: 0001562180-21-003465 · primarydocument.xml · derivative · entry 5 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,859 Underlying: Common Stock · 5,430 shares Expires 2027-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 80,977 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on October 26, 2021. Read SEC document |
| May 11, 2021 Filed May 13, 2021 22:08 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,374 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-003465 · primarydocument.xml · derivative · entry 4 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,421 Underlying: Common Stock · 9,374 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 215,741 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| May 11, 2021 Filed May 13, 2021 22:08 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 14,804 | $49.68 | $735,481.97 |
DisclosureSEC source: 0001562180-21-003465 · primarydocument.xml · nonDerivative · entry 3 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,598 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 10, 2021 in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $49.50 to $49.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. Read SEC document |
| May 11, 2021 Filed May 13, 2021 22:08 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 9,374 | $10.80 | $101,239.20 |
DisclosureSEC source: 0001562180-21-003465 · primarydocument.xml · nonDerivative · entry 2 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2021 Filed May 13, 2021 22:08 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 5,430 | $10.72 | $58,209.60 |
DisclosureSEC source: 0001562180-21-003465 · primarydocument.xml · nonDerivative · entry 1 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,028 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:15 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,335 | $0.00 Strike: $10.72 | $0.00 |
DisclosureSEC source: 0001562180-21-001949 · primarydocument.xml · derivative · entry 6 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,289 Underlying: Common Stock · 4,335 shares Expires 2027-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the 80,977 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on October 26, 2021. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:15 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,665 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-001949 · primarydocument.xml · derivative · entry 5 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,795 Underlying: Common Stock · 15,665 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 215,741 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:15 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 25,350 | $48.61 | $1,232,268.57 |
DisclosureSEC source: 0001562180-21-001949 · primarydocument.xml · nonDerivative · entry 4 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,598 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $48.19 to $49.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:15 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 900 | $49.61 | $44,651.34 |
DisclosureSEC source: 0001562180-21-001949 · primarydocument.xml · nonDerivative · entry 3 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,948 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1. F2 · price: Represents the weighted average sale price of the shares sold ranging from $49.29 to $49.92 per share, inclusive. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:15 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 15,665 | $10.80 | $169,182.00 |
DisclosureSEC source: 0001562180-21-001949 · primarydocument.xml · nonDerivative · entry 2 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:15 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 4,335 | $10.72 | $46,471.20 |
DisclosureSEC source: 0001562180-21-001949 · primarydocument.xml · nonDerivative · entry 1 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2021 Filed Feb 23, 2021 01:35 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001417 · primarydocument.xml · nonDerivative · entry 1 Nelli James Patrick Jr. · CIK 0001780883 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,848 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2021 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 21:53 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,962 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-007339 · primarydocument.xml · derivative · entry 3 Nelli James Patrick Jr. · CIK 0001780883 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,460 Underlying: Common Stock · 15,962 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 215,741 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 21:53 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 15,962 | $40.04 | $639,159.98 |
DisclosureSEC source: 0001562180-20-007339 · primarydocument.xml · nonDerivative · entry 2 Nelli James Patrick Jr. · CIK 0001780883 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,848 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $39.95 to $40.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 21:53 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 15,962 | $10.80 | $172,389.60 |
DisclosureSEC source: 0001562180-20-007339 · primarydocument.xml · nonDerivative · entry 1 Nelli James Patrick Jr. · CIK 0001780883 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 00:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,811 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-007296 · primarydocument.xml · derivative · entry 6 Nelli James Patrick Jr. · CIK 0001780883 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,422 Underlying: Common Stock · 2,811 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 215,741 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 00:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,811 | $40.01 | $112,474.29 |
DisclosureSEC source: 0001562180-20-007296 · primarydocument.xml · nonDerivative · entry 4 Nelli James Patrick Jr. · CIK 0001780883 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,848 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1. F3 · price: Represents the weighted average sale price of the shares sold ranging from $39.95 to $40.30 per share, inclusive. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 00:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 2,811 | $10.80 | $30,358.80 |
DisclosureSEC source: 0001562180-20-007296 · primarydocument.xml · nonDerivative · entry 3 Nelli James Patrick Jr. · CIK 0001780883 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2020 Filed Dec 16, 2020 00:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,227 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-007296 · primarydocument.xml · derivative · entry 5 Nelli James Patrick Jr. · CIK 0001780883 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,233 Underlying: Common Stock · 1,227 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 215,741 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| December 11, 2020 Filed Dec 16, 2020 00:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,227 | $39.95 | $49,023.68 |
DisclosureSEC source: 0001562180-20-007296 · primarydocument.xml · nonDerivative · entry 2 Nelli James Patrick Jr. · CIK 0001780883 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,848 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $39.95 to $39.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| December 11, 2020 Filed Dec 16, 2020 00:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,227 | $10.80 | $13,251.60 |
DisclosureSEC source: 0001562180-20-007296 · primarydocument.xml · nonDerivative · entry 1 Nelli James Patrick Jr. · CIK 0001780883 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.